Sibutramine: A Novel New Agent for Obesity Treatment
Open accessThe DOI matches its Crossref record.
Abstract
Sibutramine is a novel new pharmacologic agent which is a specific reuptake inhibitor for norepinephrine and serotonin. Preclinical data show that sibutramine and its two metabolites reduce food intake of animals eating either high or low carbohydrate diets and of obese Zucker rats. An 8‐week clinical trial showed a dose‐dependent decrease on body weight. Sibutramine, 5 and 20 mg/day, produced a dose‐related weight loss in obese subjects compared to placebo in an 8‐week trial. In doses varying from 1 to 30 mg, sibutramine also produced a dose‐dependent decrease in weight in the healthy obese population when used in 6‐,8‐,12–24‐ and 52‐week trials. Although the majority of the weight loss occurred during the first 12 weeks of treatment, weight loss had not plateaued in by 24 weeks in the higher doses. Side effects were mild. This drug shows promise as an antiobesity drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
August, G. P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F. R., Lustig, R. H., Silverstein, J. H., Speiser, P. W., Styne, D. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2458 · Cited by 524
Sibutramine Produces Dose‐Related Weight Loss
Bray, G. A., Blackburn, G. L., Ferguson, J. M., Greenway, F. L., Jain, A. K., Mendel, C. M., Mendels, J., Ryan, D. H., Schwartz, S. L., Scheinbaum, M. L., et al. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00701.x · Cited by 382
Self-citationCurrent and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
Self-citationLong-term Weight Loss With Sibutramine: A Randomized Controlled Trial
Wirth, A., & Krause, J. (2001) · JAMA · doi:10.1001/jama.286.11.1331 · Cited by 272
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
“In initial clinical trials for weight loss, it was found to decrease food intake and increase energy expenditure, and it resulted in significant dose-dependent sustainable weight loss (77% achieved a 5% weight loss by 6 months) with improvements in lipids and glycemic control indices.(56,58,59) However, separate large…”
Background
Metadata
- Authors
- Ryan, D. H., Kaiser, P., & Bray, G. A.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 3
- Issue
- S4
- Pages
- 553S-559S
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W1984562645
- Cited by
- 102
- References
- 0
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sibutramine: A Novel New Agent for Obesity Treatment. https://app.cochat.ai/papers/10.1002/j.1550-8528.1995.tb00227.x
- The paper
- Ryan, D. H., Kaiser, P., & Bray, G. A. (1995). Sibutramine: A Novel New Agent for Obesity Treatment. Obesity Research. https://doi.org/10.1002/j.1550-8528.1995.tb00227.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.